Home › Funds › GENDELL JEFFREY L › INDV
GENDELL JEFFREY L position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
GENDELL JEFFREY L reported holding 1,146,343 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$41.1M, representing 0.43% of its reported portfolio and ranking #24 among its reported holdings. GENDELL JEFFREY L has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How GENDELL JEFFREY L's INDV position evolved
GENDELL JEFFREY L first disclosed a stake in INDV in Q4 2024 at 303,263 shares (US$3.8M). The position peaked in Q2 2026 at 1,096,343 shares, worth US$45.0M. Across 8 filings, GENDELL JEFFREY L increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,146,343 shares valued at US$41.1M — an increase of 50,000 shares quarter over quarter.. Notable position changes include a 100% increase in Q1 2025 (shares rose 55% over the following quarter), a 41% increase in Q2 2025 (shares rose 64% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 303.26K | $3.77M | New |
| Q1 2025 | 606.48K | $5.78M | Add |
| Q2 2025 | 856.48K | $12.62M | Add |
| Q3 2025 | 1.05M | $25.23M | Add |
| Q4 2025 | 1.10M | $39.34M | Add |
| Q1 2026 | 1.10M | $33.42M | Hold |
| Q2 2026 | 1.10M | $44.98M | Hold |
| Q3 2026 | 1.15M | $41.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M sh · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
- Melqart Asset Management (UK) Ltd 585.66K sh · $24.03M · Q2 2026
More on GENDELL JEFFREY L
FAQ
How long has GENDELL JEFFREY L held INDV?
GENDELL JEFFREY L has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is GENDELL JEFFREY L's current position in INDV?
As of Q3 2026, GENDELL JEFFREY L holds 1.15M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $41.10M, representing 0.43% of its reported portfolio and ranking #24.
Has GENDELL JEFFREY L been buying or selling INDV?
In the latest 13F filing (Q3 2026), GENDELL JEFFREY L increased its position in INDV. The position peaked in Q2 2026 at 1.10M shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.